Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.560
+0.050 (1.99%)
At close: Nov 26, 2025, 4:00 PM EST
2.580
+0.020 (0.78%)
After-hours: Nov 26, 2025, 7:24 PM EST
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $89.71 million as of November 26, 2025. Its market cap has increased by 2,571.32% in one year.
Market Cap
89.71M
Enterprise Value
82.30M
1-Year Change
2,571.32%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has increased from $41.18M to $89.71M, an increase of 117.85%. That is a compound annual growth rate of 22.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 89.71M | 2,185.42% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 991.27B |
| Johnson & Johnson | 499.45B |
| AbbVie | 403.76B |
| UnitedHealth Group | 298.34B |
| AstraZeneca | 288.24B |
| Merck & Co. | 260.61B |
| Novartis AG | 248.38B |
| Abbott Laboratories | 223.41B |